Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

This Day in MV History: Biotech/pharma

By

PrintPRINT

These articles were published on Minyanville.com on 26th April in History. Checkout how time flies, enjoy reading!

Vertex Rises on Hope for Hepatitis C Drug

on Apr 26, 2011 1:15 pm by Brett Chase

Vertex Pharmaceuticals' (VRTX) shares are rising after Food and Drug Administration staff said the company's hepatitis C drug, telaprevir, appears to be effective in treating the chronic, liver-destroying virus. "The FDA review team's independent analyses confirmed (Vertex's) primary efficacy findings and many secondary endpoint analyses for all pivotal clinical trial... Read More


Regeneron Shares Jump on Strong Sales of Eye Drug

on Apr 26, 2012 12:50 pm by Brett Chase

MINYANVILLE ORIGINAL Under-promising and over-delivering is not a common practice in biotech. And yet here is Regeneron Pharmaceuticals (REGN) for the second straight quarter, shattering expectations for its new eye drug. Regeneron reported $124 million in sales in the first quarter for Eylea, an injected drug that treats age-related macular degeneration, which is a leading cause of blindness i... Read More
< Previous
  • 1
Next >
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE